Summit Healthcare Acquisition Corp.
Definitive Agreement
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $200M
- Focus
- Healthcare, Pharmaceuticals, Technology
- SEC Filings
- 1839185
Target Information
Information on the SPAC target for merger.
- Company
- YS Biopharma (YishengBio)